However, especially in human medicine, recent findings have highlighted the role of TILs, TAMs and the expression of immune checkpoint molecules such as PD-1, PD-L1, and PD-L2 in modulating tumor behavior and activating the immune response. Here, PDCD1 is linked to neoplasm.